Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Driver developed and launched a digital health platform combining tumor molecular profiling with an app to match cancer patients to clinical trials. The company operated pathology labs in the US and China for tumor sequencing. Despite raising ~$90–100 million in venture capital and partnering with major cancer centers, it failed to gain traction due to high costs for patients ($3,000 upfront plus $20/month) and lack of paying institutional customers. The company ceased operations within two months of its public launch in late 2018.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Driver.